In vitro activity of BMY 28100, a new oral cephalosporin

J. Steele, B. Edwards, J. Rissing

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BMY 28100, a new oral cephalosporin, demonstrated good in vitro activity against common gram-positive and gram-negative respiratory and urinary tract pathogens. Its activity was shown by microdilution techniques to be generally higher than those of ampicillin, cephalothin and cephalexin, but comparable to those of cefaclor and, except for Haemophilus spp. and Brantiamella spp., to amoxicillin/clavulanate.

Original languageEnglish (US)
Pages (from-to)111-113
Number of pages3
JournalEuropean Journal of Clinical Microbiology
Volume6
Issue number1
DOIs
StatePublished - Feb 1 1987

Fingerprint

Cefaclor
Haemophilus
Cephalexin
Cephalothin
Clavulanic Acid
Amoxicillin
Cephalosporins
Ampicillin
Urinary Tract
Respiratory System
In Vitro Techniques
cefprozil

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

In vitro activity of BMY 28100, a new oral cephalosporin. / Steele, J.; Edwards, B.; Rissing, J.

In: European Journal of Clinical Microbiology, Vol. 6, No. 1, 01.02.1987, p. 111-113.

Research output: Contribution to journalArticle

@article{e1d695ff12144af39365066ac1fd99d4,
title = "In vitro activity of BMY 28100, a new oral cephalosporin",
abstract = "BMY 28100, a new oral cephalosporin, demonstrated good in vitro activity against common gram-positive and gram-negative respiratory and urinary tract pathogens. Its activity was shown by microdilution techniques to be generally higher than those of ampicillin, cephalothin and cephalexin, but comparable to those of cefaclor and, except for Haemophilus spp. and Brantiamella spp., to amoxicillin/clavulanate.",
author = "J. Steele and B. Edwards and J. Rissing",
year = "1987",
month = "2",
day = "1",
doi = "10.1007/BF02097214",
language = "English (US)",
volume = "6",
pages = "111--113",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Vieweg",
number = "1",

}

TY - JOUR

T1 - In vitro activity of BMY 28100, a new oral cephalosporin

AU - Steele, J.

AU - Edwards, B.

AU - Rissing, J.

PY - 1987/2/1

Y1 - 1987/2/1

N2 - BMY 28100, a new oral cephalosporin, demonstrated good in vitro activity against common gram-positive and gram-negative respiratory and urinary tract pathogens. Its activity was shown by microdilution techniques to be generally higher than those of ampicillin, cephalothin and cephalexin, but comparable to those of cefaclor and, except for Haemophilus spp. and Brantiamella spp., to amoxicillin/clavulanate.

AB - BMY 28100, a new oral cephalosporin, demonstrated good in vitro activity against common gram-positive and gram-negative respiratory and urinary tract pathogens. Its activity was shown by microdilution techniques to be generally higher than those of ampicillin, cephalothin and cephalexin, but comparable to those of cefaclor and, except for Haemophilus spp. and Brantiamella spp., to amoxicillin/clavulanate.

UR - http://www.scopus.com/inward/record.url?scp=0023139206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023139206&partnerID=8YFLogxK

U2 - 10.1007/BF02097214

DO - 10.1007/BF02097214

M3 - Article

VL - 6

SP - 111

EP - 113

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 1

ER -